CA Stock MarketDetailed Quotes

PHRX Pharmadrug Inc

Watchlist
  • 0.020
  • 0.0000.00%
15min DelayMarket Closed Jun 28 14:32 ET
2.09MMarket Cap-85P/E (TTM)

Pharmadrug Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
65.51%-671.88K
-100.50%-15.97K
93.90%-200.86K
73.45%-130.02K
91.03%-92.26K
34.43%-1.95M
644.77%3.17M
-403.12%-3.29M
-2.88%-489.65K
27.55%-1.03M
Net income from continuing operations
-332.83%-13.26M
-625.81%-12.36M
89.70%-300.01K
52.77%-419.98K
88.93%-178.77K
28.48%-3.06M
301.05%2.35M
-203.45%-2.91M
-12.98%-889.29K
11.68%-1.61M
Operating gains losses
129.72%160.65K
-194.35%-16.57K
108.80%49.11K
--71.76K
--56.35K
40.14%-540.59K
--17.56K
---558.15K
----
----
Depreciation and amortization
24.67%26.22K
407.66%26.22K
--0
--0
--0
31.28%21.03K
-553.49%-8.52K
2.04%5.71K
45.15%11.15K
-96.94%9.88K
Asset impairment expenditure
--11.12M
----
----
----
----
--0
----
----
----
----
Unrealized gains and losses of investment securities
-120.67%-122.27K
-92.81%16.39K
-82.62%23.15K
-103.34%-2.96K
-212.20%-158.84K
-63.51%591.47K
-44.80%227.99K
-28.27%133.2K
-7.87%88.71K
-84.71%141.58K
Remuneration paid in stock
404.92%1.74M
--1.74M
--0
--0
--0
-42.52%344.76K
--0
-98.04%2.22K
-95.35%9.06K
52.46%333.57K
Deferred tax
-431.76%-1.01M
----
----
----
----
---190K
----
----
----
----
Other non cashItems
89.90%384.33K
110.55%180.05K
-23.60%26.89K
119.39%89.97K
155.22%87.42K
79.26%202.39K
800.51%85.51K
4.15%35.2K
20.00%41.01K
-3.33%34.25K
Change In working capital
-57.21%294.04K
----
----
-47.47%131.18K
52.78%101.58K
615.98%687.22K
----
----
1,248.67%249.72K
163.31%66.49K
-Change in receivables
106.66%3.78K
----
----
97.14%-3.86K
260.43%13.65K
-193.84%-56.68K
----
----
-388.12%-134.94K
83.00%-8.51K
-Change in inventory
--0
----
----
--0
--0
2,808.36%73.41K
----
----
573.81%41.07K
-88.95%2.16K
-Change in prepaid assets
-70.25%8.68K
----
----
-92.58%4.56K
115.57%4.56K
243.68%29.17K
----
----
12.82%61.46K
66.94%-29.27K
-Change in payables and accrued expense
-38.46%351.58K
----
----
-53.75%130.49K
-18.35%83.37K
424.96%571.32K
----
----
346.64%282.13K
627.48%102.11K
-Change in other working capital
-200.00%-70K
----
----
----
----
--70K
----
----
----
----
Cash from discontinued investing activities
0
0
0
73.28%-309.34K
47.12%-129.29K
-223.6K
Operating cash flow
70.23%-671.88K
-100.56%-15.97K
93.90%-200.86K
78.99%-130.02K
92.63%-92.26K
45.33%-2.26M
352.57%2.86M
-285.12%-3.29M
14.09%-618.94K
11.80%-1.25M
Investing cash flow
Cash flow from continuing investing activities
1,114.75%995.04K
686.69%741.24K
131.76%8.04K
37.84K
207.92K
-94.62%81.91K
153.08%94.22K
104.04%3.47K
0
0
Net business purchase and sale
6,197.21%741.54K
500,942.57%741.54K
--0
----
----
-103.93%-12.16K
14,900.00%148
106.56%3.47K
----
----
Net investment purchase and sale
169.46%253.5K
-100.32%-300
--8.04K
--37.84K
--207.92K
-92.25%94.08K
9,407,400.00%94.08K
--0
--0
--0
Cash from discontinued investing activities
0
0
0
0
0
89.85%-4.34K
0
0
-2.76K
-1.58K
Investing cash flow
1,182.65%995.04K
686.69%741.24K
131.76%8.04K
1,472.32%37.84K
13,267.95%207.92K
-94.76%77.58K
2,056.46%94.22K
104.00%3.47K
33.26%-2.76K
-100.10%-1.58K
Financing cash flow
Cash flow from continuing financing activities
-74.40%225.51K
-75.86%93.15K
-3,546.43%-116.54K
4.74%880.87K
328.78%385.9K
-100.38%-3.2K
Net issuance payments of debt
-99.34%4K
----
----
6,566.67%100K
-2,903.75%-96K
--601.8K
----
----
--1.5K
81.24%-3.2K
Net common stock issuance
--0
----
----
--0
----
--280K
----
----
--280K
----
Cash dividends paid
--0
----
----
--0
--0
--0
----
----
--0
--0
Proceeds from stock option exercised by employees
--0
----
----
--0
----
-88.89%106K
----
----
17.78%106K
----
Interest paid (cash flow from financing activities)
-100.19%-78.49K
----
----
---6.85K
---20.54K
65.29%-39.21K
----
----
--0
--0
Net other financing activities
542.97%300K
----
----
----
----
---67.72K
----
----
---1.6K
----
Cash from discontinued financing activities
0
0
0
41.24%-37.63K
-52.11%-25.15K
-13.17K
Financing cash flow
-73.26%225.51K
----
----
-74.18%93.15K
-612.26%-116.54K
8.53%843.25K
----
----
391.04%360.75K
-101.94%-16.36K
Net cash flow
Beginning cash position
-99.12%8.41K
474.15%160.1K
-48.54%9.92K
-89.18%8.36K
-99.11%8.56K
-55.13%957.98K
-98.40%27.88K
-99.34%19.28K
-97.81%77.26K
-55.13%957.98K
Current changes in cash
141.06%548.67K
1,157.09%399.41K
-39.99%149.18K
100.37%962
99.93%-880
28.57%-1.34M
96.72%-37.78K
123.24%248.61K
59.92%-260.94K
-226.84%-1.27M
Effect of exchange rate changes
-99.21%3.05K
-95.81%773
100.41%993
-99.73%600
-99.82%686
-44.25%386.91K
-94.91%18.46K
-190.64%-240.01K
1,124.92%218.75K
-1.69%389.71K
Cash adjustments other than cash changes
----
----
--0
--0
----
----
----
--0
---15.78K
----
End cash Position
6,447.39%560.13K
6,447.39%560.13K
474.15%160.1K
-48.54%9.92K
-89.18%8.36K
-99.11%8.56K
-99.11%8.56K
-98.40%27.88K
-99.34%19.28K
-97.81%77.26K
Free cash from
70.23%-671.88K
-100.56%-15.97K
93.90%-200.86K
78.99%-130.02K
92.63%-92.26K
45.33%-2.26M
361.15%2.86M
-270.77%-3.29M
14.58%-618.94K
11.80%-1.25M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 65.51%-671.88K-100.50%-15.97K93.90%-200.86K73.45%-130.02K91.03%-92.26K34.43%-1.95M644.77%3.17M-403.12%-3.29M-2.88%-489.65K27.55%-1.03M
Net income from continuing operations -332.83%-13.26M-625.81%-12.36M89.70%-300.01K52.77%-419.98K88.93%-178.77K28.48%-3.06M301.05%2.35M-203.45%-2.91M-12.98%-889.29K11.68%-1.61M
Operating gains losses 129.72%160.65K-194.35%-16.57K108.80%49.11K--71.76K--56.35K40.14%-540.59K--17.56K---558.15K--------
Depreciation and amortization 24.67%26.22K407.66%26.22K--0--0--031.28%21.03K-553.49%-8.52K2.04%5.71K45.15%11.15K-96.94%9.88K
Asset impairment expenditure --11.12M------------------0----------------
Unrealized gains and losses of investment securities -120.67%-122.27K-92.81%16.39K-82.62%23.15K-103.34%-2.96K-212.20%-158.84K-63.51%591.47K-44.80%227.99K-28.27%133.2K-7.87%88.71K-84.71%141.58K
Remuneration paid in stock 404.92%1.74M--1.74M--0--0--0-42.52%344.76K--0-98.04%2.22K-95.35%9.06K52.46%333.57K
Deferred tax -431.76%-1.01M-------------------190K----------------
Other non cashItems 89.90%384.33K110.55%180.05K-23.60%26.89K119.39%89.97K155.22%87.42K79.26%202.39K800.51%85.51K4.15%35.2K20.00%41.01K-3.33%34.25K
Change In working capital -57.21%294.04K---------47.47%131.18K52.78%101.58K615.98%687.22K--------1,248.67%249.72K163.31%66.49K
-Change in receivables 106.66%3.78K--------97.14%-3.86K260.43%13.65K-193.84%-56.68K---------388.12%-134.94K83.00%-8.51K
-Change in inventory --0----------0--02,808.36%73.41K--------573.81%41.07K-88.95%2.16K
-Change in prepaid assets -70.25%8.68K---------92.58%4.56K115.57%4.56K243.68%29.17K--------12.82%61.46K66.94%-29.27K
-Change in payables and accrued expense -38.46%351.58K---------53.75%130.49K-18.35%83.37K424.96%571.32K--------346.64%282.13K627.48%102.11K
-Change in other working capital -200.00%-70K------------------70K----------------
Cash from discontinued investing activities 00073.28%-309.34K47.12%-129.29K-223.6K
Operating cash flow 70.23%-671.88K-100.56%-15.97K93.90%-200.86K78.99%-130.02K92.63%-92.26K45.33%-2.26M352.57%2.86M-285.12%-3.29M14.09%-618.94K11.80%-1.25M
Investing cash flow
Cash flow from continuing investing activities 1,114.75%995.04K686.69%741.24K131.76%8.04K37.84K207.92K-94.62%81.91K153.08%94.22K104.04%3.47K00
Net business purchase and sale 6,197.21%741.54K500,942.57%741.54K--0---------103.93%-12.16K14,900.00%148106.56%3.47K--------
Net investment purchase and sale 169.46%253.5K-100.32%-300--8.04K--37.84K--207.92K-92.25%94.08K9,407,400.00%94.08K--0--0--0
Cash from discontinued investing activities 0000089.85%-4.34K00-2.76K-1.58K
Investing cash flow 1,182.65%995.04K686.69%741.24K131.76%8.04K1,472.32%37.84K13,267.95%207.92K-94.76%77.58K2,056.46%94.22K104.00%3.47K33.26%-2.76K-100.10%-1.58K
Financing cash flow
Cash flow from continuing financing activities -74.40%225.51K-75.86%93.15K-3,546.43%-116.54K4.74%880.87K328.78%385.9K-100.38%-3.2K
Net issuance payments of debt -99.34%4K--------6,566.67%100K-2,903.75%-96K--601.8K----------1.5K81.24%-3.2K
Net common stock issuance --0----------0------280K----------280K----
Cash dividends paid --0----------0--0--0----------0--0
Proceeds from stock option exercised by employees --0----------0-----88.89%106K--------17.78%106K----
Interest paid (cash flow from financing activities) -100.19%-78.49K-----------6.85K---20.54K65.29%-39.21K----------0--0
Net other financing activities 542.97%300K-------------------67.72K-----------1.6K----
Cash from discontinued financing activities 00041.24%-37.63K-52.11%-25.15K-13.17K
Financing cash flow -73.26%225.51K---------74.18%93.15K-612.26%-116.54K8.53%843.25K--------391.04%360.75K-101.94%-16.36K
Net cash flow
Beginning cash position -99.12%8.41K474.15%160.1K-48.54%9.92K-89.18%8.36K-99.11%8.56K-55.13%957.98K-98.40%27.88K-99.34%19.28K-97.81%77.26K-55.13%957.98K
Current changes in cash 141.06%548.67K1,157.09%399.41K-39.99%149.18K100.37%96299.93%-88028.57%-1.34M96.72%-37.78K123.24%248.61K59.92%-260.94K-226.84%-1.27M
Effect of exchange rate changes -99.21%3.05K-95.81%773100.41%993-99.73%600-99.82%686-44.25%386.91K-94.91%18.46K-190.64%-240.01K1,124.92%218.75K-1.69%389.71K
Cash adjustments other than cash changes ----------0--0--------------0---15.78K----
End cash Position 6,447.39%560.13K6,447.39%560.13K474.15%160.1K-48.54%9.92K-89.18%8.36K-99.11%8.56K-99.11%8.56K-98.40%27.88K-99.34%19.28K-97.81%77.26K
Free cash from 70.23%-671.88K-100.56%-15.97K93.90%-200.86K78.99%-130.02K92.63%-92.26K45.33%-2.26M361.15%2.86M-270.77%-3.29M14.58%-618.94K11.80%-1.25M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg